|  Help  |  About  |  Contact Us

Publication : Knockout of the Tachykinin Receptor 1 in the Mdr2<sup>-/-</sup> (Abcb4<sup>-/-</sup>) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

First Author  Ceci L Year  2020
Journal  Am J Pathol Volume  190
Issue  11 Pages  2251-2266
PubMed ID  32712019 Mgi Jnum  J:297479
Mgi Id  MGI:6472808 Doi  10.1016/j.ajpath.2020.07.007
Citation  Ceci L, et al. (2020) Knockout of the Tachykinin Receptor 1 in the Mdr2(-/-) (Abcb4(-/-)) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis. Am J Pathol 190(11):2251-2266
abstractText  Activation of the substance P (SP)/neurokinin 1 receptor (NK1R) axis triggers biliary damage/senescence and liver fibrosis in bile duct ligated and Mdr2(-/-) (alias Abcb4(-/-)) mice through enhanced transforming growth factor-beta1 (TGF-beta1) biliary secretion. Recent evidence indicates a role for miR-31 (MIR31) in TGF-beta1-induced liver fibrosis. We aimed to define the role of the SP/NK1R/TGF-beta1/miR-31 axis in regulating biliary proliferation and liver fibrosis during cholestasis. Thus, we generated a novel model with double knockout of Mdr2(-/-) and NK1R(-/) (alias Tacr1(-/-)) to further address the role of the SP/NK1R axis during chronic cholestasis. In vivo studies were performed in the following 12-week-old male mice: (i) NK1R(-/-); (ii) Mdr2(-/-); and (iii) NK1R(-/-)/Mdr2(-/-) (Tacr1(-/-)/Abcb4(-/-)) and their corresponding wild-type controls. Liver tissues and cholangiocytes were collected, and liver damage, changes in biliary mass/senescence, and inflammation as well as liver fibrosis were evaluated by both immunohistochemistry in liver sections and real-time PCR. miR-31 expression was measured by real-time PCR in isolated cholangiocytes. Decreased ductular reaction, liver fibrosis, biliary senescence, and biliary inflammation were observed in NK1R(-/-)/Mdr2(-/-) mice compared with Mdr2(-/-) mice. Elevated expression of miR-31 was observed in Mdr2(-/-) mice, which was reduced in NK1R(-/-)/Mdr2(-/-) mice. Targeting the SP/NK1R and/or miR-31 may be a potential approach in treating human cholangiopathies, including primary sclerosing cholangitis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression